Turkesterone: The Natural Muscle Builder Trending in 2025

The Supplement That Broke the Internet

If you've spent any time in fitness communities online, you've encountered turkesterone — an ecdysteroid compound derived from the Ajuga turkestanica plant that influencers claim can build muscle "like steroids but naturally." Sales of turkesterone supplements have skyrocketed since 2021, with market analysts estimating a 400% increase in revenue through 2024. But behind the hype lies a complicated story of insect hormones, questionable human evidence, and supplement industry economics.

What Is Turkesterone?

Turkesterone belongs to a class of compounds called ecdysteroids — steroid hormones that regulate molting and metamorphosis in insects and crustaceans. Plants produce ecdysteroids as a defense mechanism against insect herbivory: when insects consume these compounds, their molting cycles are disrupted, deterring further feeding.

The specific ecdysteroid turkesterone is found in the plant Ajuga turkestanica, native to Central Asia (primarily Uzbekistan). It's structurally similar to ecdysterone (20-hydroxyecdysone), the most studied ecdysteroid, but with an additional hydroxyl group at the C-11 position that some researchers believe enhances bioactivity.

Critically, ecdysteroids are not androgens. They do not bind to the androgen receptor, do not increase testosterone, and are structurally unrelated to anabolic-androgenic steroids like testosterone or nandrolone. Any muscle-building effects would operate through entirely different molecular pathways.

The Proposed Mechanisms

Estrogen Receptor Beta (ERβ) Activation

The most credible proposed mechanism comes from a 2019 Archives of Toxicology study by Isenmann et al., which demonstrated that ecdysterone activates the estrogen receptor beta (ERβ) in skeletal muscle cells. ERβ activation in muscle tissue promotes protein synthesis through the PI3K/Akt signaling pathway — one of the same downstream pathways activated by anabolic steroids, but accessed through a completely different receptor.

This mechanism would explain how ecdysteroids could promote muscle growth without androgenic side effects — no hair loss, no prostate enlargement, no testicular suppression.

Protein Synthesis Stimulation

In vitro studies have shown that ecdysteroids increase protein synthesis in C2C12 myotubes (mouse muscle cells) by 20-30% at pharmacological concentrations. A 2015 study in Phytochemistry demonstrated that turkesterone specifically was more potent than ecdysterone at stimulating protein synthesis in cell cultures, with an effective concentration 30-40% lower.

What Does the Human Evidence Say?

The Isenmann Study (2019)

The most cited human study is a 10-week randomized, double-blind, placebo-controlled trial published by Isenmann et al. in Archives of Toxicology. Forty-six young men took either ecdysterone (from spinach extract) or placebo while following a standardized resistance training program.

The ecdysterone group showed significantly greater increases in muscle mass (measured by bioelectrical impedance) and one-rep max bench press compared to placebo. The effect was dose-dependent — participants taking the highest dose showed the greatest gains.

However, several issues limit the study's applicability to turkesterone:

• The study used ecdysterone, not turkesterone — these are related but distinct compounds
• Bioelectrical impedance is a relatively imprecise measure of muscle mass
• The study was partially funded by a supplement company
• No follow-up studies have replicated the findings

Soviet-Era Research

Much of the turkesterone hype traces back to Soviet research from the 1980s, particularly studies conducted in Uzbekistan. These studies reportedly showed dramatic muscle-building effects, but the original papers are largely unavailable in English-language journals, have not been peer-reviewed by Western standards, and cannot be independently verified.

The 2021 WADA Review

The World Anti-Doping Agency (WADA) commissioned a review of ecdysteroids in 2020 after the Isenmann study generated attention. The review, presented at the 2021 WADA symposium, concluded that while the mechanistic evidence for ecdysteroid bioactivity was "plausible," the human evidence was "insufficient to warrant addition to the prohibited list at this time." WADA continues to monitor the compound class.

The Supplement Industry Problem

Purity and Dosing

Independent laboratory analyses of turkesterone supplements have revealed alarming quality control issues. A 2023 analysis by a third-party testing company found that of 12 turkesterone products tested:

• 3 contained no detectable turkesterone
• 5 contained less than 50% of the labeled dose
• Only 2 contained within 10% of the claimed amount

The raw material — Ajuga turkestanica extract — is expensive and limited in supply. The plant grows primarily in one region of Central Asia, and extraction and standardization to high turkesterone content is technically demanding. This creates strong economic incentives for adulteration.

Bioavailability Questions

Even if a supplement contains the labeled dose, ecdysteroids have notoriously poor oral bioavailability. A 2019 pharmacokinetic study in the British Journal of Pharmacology found that only 1-2% of ingested ecdysterone reached systemic circulation in rats due to extensive first-pass hepatic metabolism.

Turkesterone's bioavailability in humans hasn't been directly measured. Some manufacturers use cyclodextrin complexation or liposomal delivery systems claiming enhanced absorption, but these claims lack published supporting data.

The Effective Dose Problem

In the Isenmann study, the effective ecdysterone dose was approximately 12 mg/kg/day — which translates to roughly 960 mg/day for an 80 kg person. Most turkesterone supplements provide 500 mg/day of Ajuga turkestanica extract standardized to 10% turkesterone — meaning just 50 mg of actual turkesterone. Even assuming equivalent potency to ecdysterone (which hasn't been established), this is roughly 1/20th of the dose that showed effects in the only positive human trial.

Safety Considerations

The limited available evidence suggests ecdysteroids have a favorable safety profile. The Isenmann study reported no adverse effects. Ecdysteroids have no affinity for the androgen receptor, so androgenic side effects (acne, hair loss, liver toxicity, hormonal suppression) are not expected.

However, long-term safety data in humans simply doesn't exist. The ERβ activation mechanism raises theoretical questions about long-term estrogen receptor modulation that haven't been studied.

The Verdict

The mechanistic science is genuinely interesting. Ecdysteroids activate a legitimate anabolic signaling pathway (ERβ → PI3K/Akt) that could theoretically promote muscle growth without androgenic side effects.

The human evidence is woefully insufficient. One study with a related-but-different compound, partially industry-funded, using imprecise measurements, unreplicated, and at doses far exceeding what commercial supplements provide.

The supplement market is unreliable. Most products contain a fraction of their labeled turkesterone content, and even accurate products deliver doses far below what the limited research suggests is effective.

If you're considering turkesterone, understand that you're likely paying premium prices for an under-dosed, poorly bioavailable compound backed by one tangentially relevant human study. Your money would be better spent on creatine monohydrate — which has over 500 human studies supporting its efficacy at readily achievable doses — and a well-designed training program.